Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease

Circulation Research

Volumn 118, Issue 4, 2016, Pages 535-546

  Herrington, William ^a   Lacey, Ben ^a   Sherliker, Paul ^a   Armitage, Jane ^a   Lewington, Sarah ^a  

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

Author keywords

atherosclerosis; coronary; epidemiology; peripheral; stroke

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR AGENT;

ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; HEALTH BEHAVIOR; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LIPID BLOOD LEVEL; MORTALITY; OBESITY; PRIORITY JOURNAL; SMOKING; THROMBOSIS; COMORBIDITY; HEALTH; LIFESTYLE; PREVENTIVE HEALTH SERVICE; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TIME FACTOR;

ATHEROSCLEROSIS; CARDIOVASCULAR AGENTS; COMORBIDITY; GLOBAL HEALTH; HUMANS; LIFE STYLE; PREVENTIVE HEALTH SERVICES; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TIME FACTORS;

EID: 84959055854     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.307611     Document Type: Article

References (122)

1. Bentzon JF, Otsuka F, Virmani R, Falk E., Mechanisms of plaque formation and rupture. Circ Res 2014 114 1852 1866. doi: 10.1161/CIRCRESAHA.114.302721.
2. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M., Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation 2014 129 1483 1492. doi: 10.1161/CIRCULATIONAHA.113.004042.
3. Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor M, Lawes CM, Moran AE, Anderson LM, Roth GA, Mensah GA, Ezzati M, Murray CJ, Feigin VL, Global Burden of Diseases, Injuries, and Risk Factors 2010 Study Stroke Expert Group The global burden of ischemic stroke: findings of the GBD 2010 study. Glob Heart 2014 9 107 112. doi: 10.1016/j.gheart.2014.01.001.
4. Global Burden of Disease Study 2013 (GBD 2013) Age-Sex Specific All-Cause and Cause-Specific Mortality 1990-2013 2014 Seattle, United States Institute for Health Metrics and Evaluation (IHME)
5. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 385 117 171
6. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M., Age standardization of rates: A new WHO standard. GPE Discussion Paper Series: No. 31 2001 Geneva, Switzerland Wolrd Health Organisation
7. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, Murray CJ, Naghavi M., The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation 2014 129 1493 1501. doi: 10.1161/CIRCULATIONAHA.113.004046.
8. Alpert JS, Thygesen K, Antman E, Bassand JP., Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 36 959 969
9. Thygesen K, Alpert JS, White HD, ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction Universal definition of myocardial infarction. Eur Heart J 2007 28 2525 2538
10. Thygesen K, Alpert JS, Jaffe AS, ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction Third universal definition of myocardial infarction. Eur Heart J 2012 33 2551 2567. doi: 10.1093/eurheartj/ehs184.
11. Dégano IR, Salomaa V, Veronesi G, Ferriéres J, Kirchberger I, Laks T, Havulinna AS, Ruidavets JB, Ferrario MM, Meisinger C, Elosua R, Marrugat J, Acute Myocardial Infarction Trends in Europe (AMITIE) Study Investigators Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart 2015 101 1413 1421. doi: 10.1136/heartjnl-2014-307310.
12. Gerber Y, Weston SA, Jiang R, Roger VL., The changing epidemiology of myocardial infarction in Olmsted County, Minnesota, 1995-2012. Am J Med 2015 128 144 151. doi: 10.1016/j.amjmed.2014.09.012.
13. Smolina K, Wright FL, Rayner M, Goldacre MJ., Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: Linked national database study. BMJ 2012 344 d8059. doi: 10.1136/bmj.d8059.
14. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS., Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010 362 2155 2165. doi: 10.1056/NEJMoa0908610.
15. Rosamond WD, Chambless LE, Heiss G, Mosley TH, Coresh J, Whitsel E, Wagenknecht L, Ni H, Folsom AR., Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation 2012 125 1848 1857. doi: 10.1161/CIRCULATIONAHA.111.047480.
16. Manari A, Albiero R, De Servi S., High-risk non-ST-segment elevation myocardial infarction versus ST-segment elevation myocardial infarction: same behaviour and outcome? J Cardiovasc Med (Hagerstown) 2009 10 suppl 1 S13 S16. doi: 10.2459/01.JCM.0000362039.48638.92.
17. Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KA, Goldberg RJ, Anderson FA Jr, Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J 2009 158 193 201.e1. doi: 10.1016/j.ahj.2009.06.003.
18. Weston C GL, Whittaker T, Van Leeven R., Myocardial Ischaemia National Audit Project (MINAP): Twelfth Public Report 2013 2014 London: National Centre for Cardiovascular Prevention and Outcomes
19. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ., Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med 2011 124 40 47. doi: 10.1016/j.amjmed.2010.07.023.
20. Li J, Li X, Wang Q, Hu S, Wang Y, Masoudi FA, Spertus JA, Krumholz HM, Jiang L, China PEACE Collaborative Group ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet 2015 385 441 451. doi: 10.1016/S0140-6736(14)60921-1.
21. Townsend N, Wickramasinghe K, Bhatnagar P, Smolina K, Nichols M, Lean J, Luengo-Fernandez R, Rayner M., Coronary Heart Disease Statistics 2012 Edition 2012 London British Heart Foundation
22. Hemingway H, McCallum A, Shipley M, Manderbacka K, Martikainen P, Keskimäki I., Incidence and prognostic implications of stable angina pectoris among women and men. JAMA 2006 295 1404 1411. doi: 10.1001/jama.295.12.1404.
23. Will JC, Yuan K, Ford E., National trends in the prevalence and medical history of angina: 1988 to 2012. Circ Cardiovasc Qual Outcomes 2014 7 407 413. doi: 10.1161/CIRCOUTCOMES.113.000779.
24. Rothwell PM, Coull AJ, Silver LE, Oxford Vascular Study Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005 366 1773 1783. doi: 10.1016/S0140-6736(05)67702-1.
25. Heuschmann PU, Di Carlo A, Bejot Y, Rastenyte D, Ryglewicz D, Sarti C, Torrent M, Wolfe CD., Incidence of stroke in europe at the beginning of the 21st century. Stroke 2009 40 1557 1563
26. Gibson CL., Cerebral ischemic stroke: is gender important? J Cereb Blood Flow Metab 2013 33 1355 1361. doi: 10.1038/jcbfm.2013.102.
27. Kleindorfer DO, Khoury J, Moomaw CJ, Alwell K, Woo D, Flaherty ML, Khatri P, Adeoye O, Ferioli S, Broderick JP, Kissela BM., Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke 2010 41 1326 1331. doi: 10.1161/STROKEAHA.109.575043.
28. Krishnamurthi RV, Feigin VL, Forouzanfar MH, Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the global burden of disease study 2010. Lancet Glob Health 2013 1 e259 e281. doi: 10.1016/S2214-109X(13)70089-5.
29. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993 24 35 41
30. Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, Ayata C, Towfighi A, Smith EE, Chong JY, Koroshetz WJ, Sorensen AG., A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke 2007 38 2979 2984. doi: 10.1161/STROKEAHA.107.490896.
31. Schneider AT, Kissela B, Woo D, Kleindorfer D, Alwell K, Miller R, Szaflarski J, Gebel J, Khoury J, Shukla R, Moomaw C, Pancioli A, Jauch E, Broderick J., Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke 2004 35 1552 1556. doi: 10.1161/01.STR.0000129335.28301.f5.
32. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C., Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991 337 1521 1526
33. Kronzon I, Tunick PA., Aortic atherosclerotic disease and stroke. Circulation 2006 114 63 75. doi: 10.1161/CIRCULATIONAHA.105.593418.
34. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO., Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999 30 2513 2516
35. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL., Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005 111 1327 1331. doi: 10.1161/01.CIR.0000157736.19739.D0.
36. Schulz UG, Rothwell PM., Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 2003 34 2050 2059. doi: 10.1161/01.STR.0000079818.08343.8C.
37. Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK., Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 127 1425 1443. doi: 10.1161/CIR.0b013e31828b82aa.
38. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH., Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013 382 1329 1340. doi: 10.1016/S0140-6736(13)61249-0.
39. Selvin E, Erlinger TP., Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004 110 738 743. doi: 10.1161/01.CIR.0000137913.26087.F0.
40. Criqui MH, Aboyans V., Epidemiology of peripheral artery disease. Circ Res 2015 116 1509 1526. doi: 10.1161/CIRCRESAHA.116.303849.
41. www.mortality-trends.org (accessed 25th January 2016).
42. www.ctsu.ox.ac.uk/deathsfromsmoking/(accessed 25th January 2016).
43. Doll R., Tobacco: a medical history. J Urban Health 1999 76 289 313. doi: 10.1007/BF02345669.
44. Doll R, Hill AB., Smoking and carcinoma of the lung; preliminary report. Br Med J 1950 2 739 748
45. Doll R, Hill AB., A study of the aetiology of carcinoma of the lung. Br Med J 1952 2 1271 1286
46. Muller FH., Tabakmissbrauch und lungencarcinoma. Zeitschrift Krebsforsch 1939 49 57 85
47. Schairer E., Lungenkrebs und tabakverbrauch. Zeitschrift Krebsforsch 1943 54 261 269
48. Mills CA, Porter MM., Tobacco smoking habits and cancer of the mouth and respiratory system. Cancer Res 1950 10 539 542
49. Doll R, Hill AB., The mortality of doctors in relation to their smoking habits; a preliminary report. Br Med J 1954 1 1451 1455
50. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, Feigelson HS, Thun MJ., The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002 94 2490 2501. doi: 10.1002/cncr.101970.
51. Garfinkel L., Selection, follow-up, and analysis in the American Cancer Society prospective studies. Natl Cancer Inst Monogr 1985 67 49 52
52. Doll R, Peto R, Boreham J, Sutherland I., Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004 328 1519. doi: 10.1136/bmj.38142.554479.AE.
53. Pirie K, Peto R, Reeves GK, Green J, Beral V, Million Women Study Collaborators The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 2013 381 133 141. doi: 10.1016/S0140-6736(12)61720-6.
54. Lu L, Mackay DF, Pell JP., Meta-analysis of the association between cigarette smoking and peripheral arterial disease. Heart 2014 100 414 423. doi: 10.1136/heartjnl-2013-304082.
55. Chen Z, Smith M, Du H, Guo Y, Clarke R, Bian Z, Collins R, Chen J, Qian Y, Wang X, Chen X, Tian X, Wang X, Peto R, Li L, China Kadoorie Biobank Collaborative Group Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women. Int J Epidemiol 2015 44 1305 1319. doi: 10.1093/ije/dyv012.
56. O'Donnell M, Mente A, Rangarajan S, PURE Investigators Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014 371 612 623. doi: 10.1056/NEJMoa1311889.
57. Lewington S, Li L, Sherliker P, China Kadoorie Biobank study collaboration Seasonal variation in blood pressure and its relationship with outdoor temperature in 10 diverse regions of China: the China Kadoorie Biobank. J Hypertens 2012 30 1383 1391. doi: 10.1097/HJH.0b013e32835465b5.
58. Society of Actuaries Blood Pressure: Report of the Joint Committee on Mortality of the Association of Life Insurance Medical Directors and the Actuarial Society of America 1925 New York, NY Societies of Actuaries
59. Society of Actuaries Build and Blood Pressure Study 1959 Chicago, IL Societies of Actuaries
60. Franklin SS, Wong ND., Hypertension and cardiovascular disease: contributions of the framingham heart study. Glob Heart 2013 8 49 57. doi: 10.1016/j.gheart.2012.12.004.
61. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM., Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988 77 504 514
62. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J., Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990 335 765 774
63. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 360 1903 1913
64. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R., Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007 370 1829 1839
65. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R., Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009 373 1083 1096
66. Lieb W, Jansen H, Loley C, CARDIoGRAM Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension 2013 61 995 1001. doi: 10.1161/HYPERTENSIONAHA.111.00275.
67. International Consortium for Blood Pressure Genome-Wide Association Study Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011 478 103 109
68. Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, Cass A, Baigent C, Chalmers J, Li N, Woodward M, MacMahon S., Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: Meta-analysis of randomised controlled trials. BMJ 2013 347 f5680. doi: 10.1136/bmj.f5680.
69. Hegsted DM, Ausman LM, Johnson JA, Dallal GE., Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr 1993 57 875 883
70. Keys A, Anderson JT, Grande F., Prediction of serum-cholesterol responses of man to changes in fats in the diet. Lancet 1957 273 959 966
71. Clarke R, Frost C, Collins R, Appleby P, Peto R., Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997 314 112 117
72. Dattilo AM, Kris-Etherton PM., Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992 56 320 328
73. Mozaffarian D, Appel LJ, Van Horn L., Components of a cardioprotective diet: new insights. Circulation 2011 123 2870 2891. doi: 10.1161/CIRCULATIONAHA.110.968735.
74. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R., Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010 376 1670 1681
75. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J., Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009 302 1993 2000
76. Singh GM, Danaei G, Farzadfar F, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC); Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE); Emerging Risk Factor Collaboration (ERFC); Prospective Studies Collaboration (PSC) The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One 2013 8 e65174. doi: 10.1371/journal.pone.0065174.
77. Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, Kahn J, Afonso L, Williams KA Sr, Flack JM., Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol 2012 60 2631 2639. doi: 10.1016/j.jacc.2012.09.017.
78. Voight BF, Peloso GM, Orho-Melander M, Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012 380 572 580. doi: 10.1016/S0140-6736(12)60312-2.
79. Schwartz GG, Olsson AG, Abt M, dal-OUTCOMES Investigators Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012 367 2089 2099. doi: 10.1056/NEJMoa1206797.
80. Nordestgaard BG, Varbo A., Triglycerides and cardiovascular disease. Lancet 2014 384 626 635. doi: 10.1016/S0140-6736(14)61177-6.
81. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J., Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration Triglyceride-mediated pathways and coronary disease: Collaborative analysis of 101 studies. Lancet 2010 375 1634 1639. doi: 10.1016/S0140-6736(10)60545-4.
82. Clarke R, Peden JF, Hopewell JC, PROCARDIS Consortium Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009 361 2518 2528. doi: 10.1056/NEJMoa0902604.
83. Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J, Collaboration ERF., Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009 302 412 423
84. Laschkolnig A, Kollerits B, Lamina C, Meisinger C, Rantner B, Stadler M, Peters A, Koenig W, Stöckl A, Dähnhardt D, Böger CA, Krämer BK, Fraedrich G, Strauch K, Kronenberg F., Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts. Cardiovasc Res 2014 103 28 36. doi: 10.1093/cvr/cvu107.
85. Kassner U, Schlabs T, Rosada A, Steinhagen-Thiessen E., Lipoprotein(a)-An independent causal risk factor for cardiovascular disease and current therapeutic options. Atheroscler Suppl 2015 18 263 267. doi: 10.1016/j.atherosclerosissup.2015.02.039.
86. Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM, Stepanavage M, Liu SX, Gibbons P, Ashraf TB, Zafarino J, Mitchel Y, Barter P, Determining the Efficacy and Tolerability Investigators Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med 2010 363 2406 2415. doi: 10.1056/NEJMoa1009744.
87. Menke A, Casagrande S, Geiss L, Cowie CC., Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA 2015 314 1021 1029. doi: 10.1001/jama.2015.10029.
88. Beckman JA, Creager MA, Libby P., Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002 287 2570 2581
89. Seshasai SR, Kaptoge S, Thompson A, Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011 364 829 841
90. Sarwar N, Gao P, Seshasai SR, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010 375 2215 2222
91. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ., Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA 2012 308 1660 1667. doi: 10.1001/jama.2012.13415.
92. Jansen H, Loley C, Lieb W, CARDIoGRAM consortium Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. Atherosclerosis 2015 241 419 426. doi: 10.1016/j.atherosclerosis.2015.05.033.
93. Ross S, Gerstein HC, Eikelboom J, Anand SS, Yusuf S, Paré G., Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease. Eur Heart J 2015 36 1454 1462. doi: 10.1093/eurheartj/ehv083.
94. Turnbull FM, Abraira C, Anderson RJ, Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009 52 2288 2298. doi: 10.1007/s00125-009-1470-0.
95. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N., Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009 373 1765 1772. doi: 10.1016/S0140-6736(09)60697-8.
96. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA., 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 359 1577 1589. doi: 10.1056/NEJMoa0806470.
97. Gerstein HC, Miller ME, Ismail-Beigi F, Largay J, McDonald C, Lochnan HA, Booth GL, ACCORD Study Group Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet 2014 384 1936 1941. doi: 10.1016/S0140-6736(14)60611-5.
98. Levey AS, Coresh J., Chronic kidney disease. Lancet 2012 379 165 180. doi: 10.1016/S0140-6736(11)60178-5.
99. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT., Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010 375 2073 2081
100. Schiffrin EL, Lipman ML, Mann JF., Chronic kidney disease: effects on the cardiovascular system. Circulation 2007 116 85 97. doi: 10.1161/CIRCULATIONAHA.106.678342.
101. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF., Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011 305 1119 1127. doi: 10.1001/jama.2011.308.
102. Kono K, Fujii H, Nakai K, Goto S, Shite J, Hirata K, Fukagawa M, Nishi S., Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. Kidney Int 2012 82 344 351. doi: 10.1038/ki.2012.118.
103. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H., Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003 18 1731 1740
104. Wheeler DC, London GM, Parfrey PS, EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Investigators Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. J Am Heart Assoc 2014 3 e001363. doi: 10.1161/JAHA.114.001363.
105. Bilano V, Gilmour S, Moffiet T, d'Espaignet ET, Stevens GA, Commar A, Tuyl F, Hudson I, Shibuya K., Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet 2015 385 966 976. doi: 10.1016/S0140-6736(15)60264-1.
106. World Health Organization Global database on body mass index. http://apps.who.int/bmi/. Accessed September 11, 2015
107. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011 377 557 567. doi: 10.1016/S0140-6736(10)62037-5.
108. World Health Organization Global status report on noncommunicable diseases 2014. http://www.who.int/nmh/publications/ncd-status-report-2014/en/. Accessed September 11, 2015
109. Centre of Disease Control and Prevention Diabetes public health resource. http://www.cdc.gov/diabetes/home/. Accessed September 11, 2015
110. Ni Mhurchu C, Parag V, Nakamura M, Patel A, Rodgers A, Lam TH., Body mass index and risk of diabetes mellitus in the asia-pacific region. Asia Pacific J Clin Nutr 2006 15 127 133
111. European Network for Genetic and Genomic Epidemiology (ENGAGE) collaboration The role of adiposity in cardiometabolic traits: A mendelian randomization analysis. PLoS Med 2013 10 e1001474
112. Wing RR, Bolin P, Brancati FL, Look AHEAD Research Group Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013 369 145 154. doi: 10.1056/NEJMoa1212914.
113. Holmes MV, Lange LA, Palmer T, Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. Am J Hum Genet 2014 94 198 208. doi: 10.1016/j.ajhg.2013.12.014.
114. Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K, Calderon-Margalit R., Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med 2012 172 1644 1650
115. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 346 393 403. doi: 10.1056/NEJMoa012512.
116. Wareham NJ, Brage S., Commentary: physical activity and obesity; scientific uncertainty and the art of public health messaging. Int J Epidemiol 2013 42 1843 1845. doi: 10.1093/ije/dyt164.
117. Howard VJ, McDonnell MN., Physical activity in primary stroke prevention: just do it! Stroke 2015 46 1735 1739. doi: 10.1161/STROKEAHA.115.006317.
118. Diep L, Kwagyan J, Kurantsin-Mills J, Weir R, Jayam-Trouth A., Association of physical activity level and stroke outcomes in men and women: a meta-analysis. J Womens Health (Larchmt) 2010 19 1815 1822. doi: 10.1089/jwh.2009.1708.
119. Li J, Siegrist J., Physical activity and risk of cardiovascular disease-a meta-analysis of prospective cohort studies. Int J Environ Res Public Health 2012 9 391 407. doi: 10.3390/ijerph9020391.
120. Sofi F, Capalbo A, Cesari F, Abbate R, Gensini GF., Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008 15 247 257. doi: 10.1097/HJR.0b013e3282f232ac.
121. Sattelmair J, Pertman J, Ding EL, Kohl HW III, Haskell W, Lee IM., Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 2011 124 789 795. doi: 10.1161/CIRCULATIONAHA.110.010710.
122. Shiroma EJ, Lee IM., Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation 2010 122 743 752. doi: 10.1161/CIRCULATIONAHA.109.914721.